
    
      The study includes 2 parts, part A is to evaluate the bioequivalence of Levetiracetam (LEV)
      1500 mg intravenous (iv) infusion when compared to oral tablet, part B is to assess
      pharmacokinetic profile of LEV infusion during repeated dosing in Chinese healthy volunteers.
    
  